Methods of treating colon cancer utilizing tumor-specific antibodies
AssigneeLudwig Institute for Cancer Research
InventorsSydney Welt, Lloyd J. Old, Elsje Barendswaard, Nicholas J. Montalto, Ali Osmay Gure
Life of this patent
Estimating the term…
Abstract
This invention relates to methods of reducing the effects of colon cancer tumors. Various agents are conjugated to monoclonal antibodies which are specific for colon cancer cells. The conjugates are administered to patients having colon cancer such that the effects of the cancer are reduced.
Claims5
A method for promoting colon or gastric cancer regression in a subject in need thereof comprising administering to said subject a pharmaceutically effective amount of a conjugate of an antibody and an anti-cancer drug, wherein said antibody is specific for A33 antigen.
Dependencies are inferred from the claim text.